{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:42:23Z","timestamp":1757706143194,"version":"3.40.5"},"reference-count":13,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Stroke and Cerebrovascular Diseases"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jstrokecerebrovasdis.2018.04.015","type":"journal-article","created":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T08:46:43Z","timestamp":1525423603000},"page":"e203-e205","source":"Crossref","is-referenced-by-count":6,"title":["Is Rivaroxaban a Safe Choice for Apical Thrombus in Atrial Fibrillation Patients? A Case Report"],"prefix":"10.1016","volume":"27","author":[{"given":"Fatih","family":"Aydin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6731-4958","authenticated-orcid":false,"given":"Ozge","family":"Turgay Yildirim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayse","family":"Huseyinoglu Aydin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evrin","family":"Dagtekin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ercan","family":"Aksit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jstrokecerebrovasdis.2018.04.015_bib0010","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa022913","article-title":"Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation","volume":"349","author":"Hylek","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.04.015_bib0015","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.04.015_bib0020","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.amjcard.2014.12.016","article-title":"Prevalence of intracardiac thrombi under phenprocoumon, direct oral anticoagulants (dabigatran and rivaroxaban), and bridging therapy in patients with atrial fibrillation and flutter","volume":"115","author":"Zylla","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.04.015_bib0025","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000354315","article-title":"Dissolution of the left atrial appendage thrombus with rivaroxaban therapy","volume":"36","author":"Takasugi","year":"2013","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.04.015_bib0030","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.01.014","article-title":"Reduced smoke-like echo and resolved thrombus in the left atrium with rivaroxaban therapy in an acute cardioembolic stroke patient","volume":"23","author":"Saito","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.04.015_bib0035","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ajem.2015.05.030","article-title":"Left atrial thrombus formation after brief interruption of rivaroxaban","volume":"34","author":"Turner","year":"2016","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.04.015_bib1025","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijcard.2017.07.048","article-title":"NOACs and atrial fibrillation: Incidence and predictors of left atrial thrombus in the real world","volume":"249","author":"Bertaglia","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.04.015_bib0040","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/MBC.0000000000000671","article-title":"Newly developed left ventricular apical thrombus under dabigatran treatment","volume":"29","author":"Adar","year":"2018","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.04.015_bib0045","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ihj.2015.06.010","article-title":"Dabigatran for left ventricular thrombus","volume":"67","author":"Kolekar","year":"2015","journal-title":"Indian Heart J"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.04.015_bib0050","first-page":"19","article-title":"Fast apixaban-related resolution of left ventricular thrombi in a patient with dilated cardiomyopathy","volume":"44","author":"Elikowski","year":"2018","journal-title":"Pol Merkur Lekarski"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.04.015_bib0055","article-title":"Rapid resolution of left ventricular thrombus with apixaban therapy","volume":"5","author":"Berry","year":"2017","journal-title":"SAGE Open Med Case Rep"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.04.015_bib0060","doi-asserted-by":"crossref","first-page":"671","DOI":"10.5152\/AnatolJCardiol.2015.6285","article-title":"Dissolution of an apical thrombus by apixaban in a patient with old anteroseptal myocardial infarction","volume":"15","author":"Yan\u0131ko\u011flu","year":"2015","journal-title":"Anatol J Cardiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.04.015_bib0065","doi-asserted-by":"crossref","first-page":"e9670","DOI":"10.1097\/MD.0000000000009670","article-title":"Daily 10\u2009mg rivaroxaban as a therapy for ventricular thrombus related to left ventricular non-compaction cardiomyopathy: a case report","volume":"97","author":"Sun","year":"2018","journal-title":"Medicine (Baltimore)"}],"container-title":["Journal of Stroke and Cerebrovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305718301915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305718301915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,8]],"date-time":"2018-08-08T06:42:27Z","timestamp":1533710547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052305718301915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":13,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1052305718301915"],"URL":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2018.04.015","relation":{},"ISSN":["1052-3057"],"issn-type":[{"type":"print","value":"1052-3057"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}